A Psychiatrist, an Operator, and the Part of Motherhood Nobody Schedules For
There is a strange gap in American healthcare, and Mavida Health is a company built entirely inside it. Here is the gap: a pregnant person in the United States will see a doctor roughly a dozen times before delivery, get measured and scanned and blood-drawn at each visit, and then - after the baby arrives - be handed a single six-week checkup and sent home. The baby gets a pediatrician and a schedule of visits. The mother, statistically the person most likely to be quietly falling apart, gets a leaflet. Mavida Health looked at that arrangement and decided it was, to use a technical term, backwards.
The numbers are the sales pitch, and they are bleak in the way that makes venture capitalists lean forward. Roughly one in five mothers experiences a perinatal mood or anxiety disorder - a figure that climbed toward one in three during the pandemic. Maternal mental health conditions are a leading cause of maternal mortality in the country. And yet the standard-of-care response has historically been some combination of "sleep when the baby sleeps" and a referral to a therapist who does not take your insurance and cannot see you until spring. If you were designing a market with enormous unmet need and almost no dedicated supply, you could not do much better than this one. That is, more or less, the market.
Mavida Health was founded in 2023 in Los Angeles by two people who came at the problem from opposite ends and met in the middle. Dr. Sarah Oreck is a Columbia-trained psychiatrist with a fellowship in reproductive psychiatry - which is to say she is one of a relatively small number of doctors formally trained in exactly the thing the system ignores. She is also a mother of three who has spoken openly about a second-trimester loss. She did not have to imagine the failure mode; she had lived inside it. "I dreamt up Mavida Health," she has said, "as a way to leverage technology to provide increased access to better maternal mental health care." That is a founder origin story that does not require embellishment, so it doesn't get any here.
Emma Sugerman, the co-founder and COO, is the operator half. Her resume reads like a tour of the modern mental-health-tech industry: Vice President of Care Strategy at Charlie Health, Head of Digital Strategy & Operations at LifeStance Health, and Director of Business Strategy at Headspace, with an MBA from USC Marshall on top. If Oreck knows what good care looks like clinically, Sugerman knows how to make that care exist at scale, across state lines, inside an app, without the whole thing collapsing under its own operational weight. Both women built the company, in their telling, partly out of their own experiences as mothers. Companies founded on personal grievance tend to have unusually clear product roadmaps, because the founders already know precisely what annoyed them.
The Village, Rebuilt as Software
Mavida's organizing metaphor is a small rewrite of a familiar proverb. It takes a village to raise a child, the saying goes; Mavida's version is that it takes a village to raise a mother. This is the kind of line that could be pure marketing, except that it maps directly onto the product architecture. The company does not just offer one-on-one therapy - though it does offer that, with clinicians trained in perinatal mental health. It also runs group therapy, peer support groups, discussion forums, family and couples counseling, guided meditation, and, crucially, psychiatric prescribing. The bet is that a new mother's mental health is not an individual problem to be solved in a 50-minute vacuum but a systemic one involving her partner, her hormones, her sleep, and other people going through the same thing at 3 a.m.
The commercial model is deliberately layered. There is a membership - reported around $99 a year after a free trial - that buys content, community, and group support and functions as the accessible on-ramp. Then there is the clinical care - the actual therapy and prescribing - billed separately, with insurance coverage phasing in over time. It is a sensible structure for a health company that wants to be both a consumer product people will actually download and a legitimate clinical operation that can prescribe medication. Users start by downloading the iOS app and completing a clinical assessment questionnaire, which routes them toward the level of care they need rather than the level of care a marketing funnel would prefer to sell them.
From One State to Four to a Subsidiary
Regulated healthcare does not scale the way software scales, and Mavida's growth reflects the difference. Delivering clinical care means holding licenses in every state you operate in, which is slow, expensive, and non-negotiable. The company launched offering clinical services in California only, with content and community available nationwide, and then methodically expanded its licensed clinical footprint to include New York, New Jersey, and Texas. Four states is not a rounding error in this business; it is four separate regulatory regimes cleared, one at a time.
The fundraising was correspondingly lean. Mavida raised $1.5 million in pre-seed funding, announced in September 2023 and led by Lakehouse Ventures, an early-stage firm that backs founders in the earliest days of company formation. The founders described the round as runway for roughly 12 to 15 months of product development and hiring - a small, focused raise for a small, focused team of around 18 people. One detail the founders flagged as a surprise: the idea resonated most strongly with an investor audience they had not fully expected, a reminder that maternal mental health is a market whose demand is broader and more personal than the org charts suggest.
Then, in June 2026, the plot turned. WPS Health Solutions - a large American insurer - acquired Mavida Health to enter the digital maternal mental care sector, framing the deal as strategic growth and revenue diversification beyond its core insurance-administration business. Under the arrangement, Mavida continues as an independent subsidiary with its own leadership, with WPS Chief Growth Officer Rochelle Myers stepping in as President to oversee regional expansion, and Wisconsin named as the first new priority state. The conditions Mavida treats were spelled out plainly in the announcement: PMDD, fertility issues, pregnancy loss, postpartum complications, and perimenopause - the full arc of the reproductive life, not just the newborn photo op.
The interesting thing about an insurer buying a maternal mental health startup is the incentive alignment, which for once points in a humane direction. Insurers pay for the downstream consequences of untreated perinatal mental illness - the ER visits, the complications, the long tail of costs. A company that catches those conditions early is, from the payer's chair, both the right thing and the cheap thing, which is the rare combination that gets deals done. Mavida spent two and a half years proving the clinical model works across four states; WPS bought the proof and the license to expand it.
What You Can Actually Do With It
Stripped of the funding drama, Mavida is a place a woman can go when the standard system has nothing scheduled for her. If you are pregnant and anxious in a way that does not fit the cheerful pregnancy-app template, you can talk to someone who specializes in exactly that. If you are three weeks postpartum and something is wrong that the six-week checkup will not catch in time, you can be assessed now, join a group of people in the same fog, involve your partner in couples counseling, and - if it is warranted - be prescribed medication by a psychiatrist rather than told to wait it out. If you are navigating pregnancy loss or the hormonal upheaval of perimenopause, there is a lane for that too. The pitch is not that Mavida invented therapy. It is that Mavida put the specialists, the community, and the prescribing pad in one app aimed squarely at the life stages the rest of the system treats as afterthoughts.
That is a narrow thesis, and narrowness is the point. Plenty of mental-health startups chase the broad, comfortable market of anxious young professionals. Mavida chose mothers with postpartum depression and PMDD - a harder market, a deeper need, and, as it turned out, one an insurance company was willing to pay real money to own. Sometimes the fix is not more resilience from the patient. It is somebody finally building the thing that should have existed all along.